4.7 Article

PYR-41, an inhibitor of ubiquitin-activating enzyme E1, attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice

Related references

Note: Only part of the references are listed.
Review Dermatology

Atopic dermatitis: the skin barrier and beyond

T. Tsakok et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Article Medicine, General & Internal

Update on Atopic Dermatitis

Tiago Torres et al.

ACTA MEDICA PORTUGUESA (2019)

Review Dermatology

Review of Atopic Dermatitis and Topical Therapies

Julia N. Mayba et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2017)

Review Medicine, General & Internal

Biological Treatments in Atopic Dermatitis

Andrea Montes-Torres et al.

JOURNAL OF CLINICAL MEDICINE (2015)

Review Allergy

IgE, Mast Cells, and Eosinophils in Atopic Dermatitis

Fu-Tong Liu et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)

Review Medicine, General & Internal

Triggers of IgE class switching and allergy development

Lars K. Poulsen et al.

ANNALS OF MEDICINE (2007)